Search

A study conducted in Shanghai, China, investigated the association between type 2 diabetes mellitus (T2DM) and Klebsiella pneumoniae colonization (KPC) in patients. The research identified key risk factors for KPC in T2DM patients, such as recent hospitalization, elevated white blood cell count, and decreased hemoglobin levels. A clinical prediction model was developed to identify high-risk patients for KPC, with an area under the receiver operating characteristic (ROC) curve of 0.74. This study highlights the importance of early identification and targeted interventions for T2DM patients at risk of secondary KPC. [Extracted from the article]

A recent study conducted at Shanghai Jiao Tong University in China explored the association between sudomotor dysfunction and subclinical carotid atherosclerosis (SCAS) in individuals with type 2 diabetes. The research, which included 1788 participants, found that those with sudomotor dysfunction had a higher prevalence of SCAS compared to those with normal sudomotor function. The study concluded that sudomotor dysfunction is significantly related to SCAS in people with type 2 diabetes. [Extracted from the article]

Researchers at Shanghai Jiao Tong University conducted a study on Type 2 Diabetes, focusing on the use of 1-hour postload glucose as a marker for impaired B-cell function. The study involved 496 participants at high risk of diabetes, categorizing them based on oral glucose tolerance test results. The research found that 1-hour postload glucose was more sensitive in identifying individuals at high risk of Type 2 Diabetes compared to 2-hour postload glucose, indicating potential for early detection. The study was supported by the Shanghai Oriental Talent Program and has been peer-reviewed. [Extracted from the article]

Researchers at Shanghai Sixth People's Hospital conducted a study on the association between time spent in a tight glucose range and incident diabetic retinopathy in adults with type 2 diabetes. The study found that time in the tight range (TITR) was inversely associated with the incidence of diabetic retinopathy, even among adults with well-controlled glucose levels. This research provides valuable insights into glucose control for individuals with type 2 diabetes. The study was supported by the Program of Shanghai Academic Research Leader and has been peer-reviewed. [Extracted from the article]

A study conducted by Shanghai Jiao Tong University investigated serum metabolomic biomarkers associated with incident type 2 diabetes mellitus (T2DM) in the Multi-Ethnic Study of Atherosclerosis and The Rotterdam Study. The research identified 19 metabolites significantly associated with T2DM, revealing disturbances in aminoacyl-tRNA biosynthesis, metabolism of branched-chain amino acids, glycolysis/gluconeogenesis, and glycerolipid metabolism. The study concluded that these metabolites provided modest to moderate predictive utility beyond traditional risk factors for T2DM. [Extracted from the article]

A study conducted by researchers at the Second Military Medical University in Shanghai, China, compared the outcomes of laparoscopic and open liver resection in patients with hepatocellular carcinoma and type 2 diabetes mellitus. The study found that patients who underwent laparoscopic liver resection had better overall survival and fewer complications compared to those who underwent open liver resection. The research concluded that laparoscopic liver resection can be safely performed with favorable outcomes for patients with hepatocellular carcinoma and type 2 diabetes mellitus. [Extracted from the article]

A study conducted at Shanghai Jiao Tong University focused on the impact of GLP-1 receptor agonist therapy on lipid profiles in patients with type 2 diabetes. The research found that patients with early-stage type 2 diabetes displayed significant lipidomic abnormalities that were partially improved after treatment with dulaglutide and liraglutide. The study highlighted specific lipid species that were altered in response to the treatments, indicating potential benefits for managing type 2 diabetes. [Extracted from the article]

A study conducted at Shanghai East Hospital in China explored the synergistic effect of combining glibenclamide with vitexin on type 2 diabetes mellitus (T2DM) in rats. The research found that the co-administration of these two substances increased the systemic exposure and metabolic stability of glibenclamide, leading to a significant hypoglycemic effect on T2DM rats. The study suggests that the combination of drugs with herbs could be a prevalent treatment for metabolic and chronic diseases. [Extracted from the article]

Researchers at Shanghai University of Sport have conducted a study on the link between exercise-induced microbial changes and the prevention of type 2 diabetes. The study found that physical fitness negatively correlated with diabetes-associated metagenomic species in a cohort of Chinese athlete students. The research suggests that exercise plays a protective role against type 2 diabetes by influencing gut microbiota. This peer-reviewed study provides valuable insights into the potential benefits of exercise in preventing diabetes. [Extracted from the article]

A recent meta-analysis conducted by researchers from Shanghai University of Sport examined the impact of type 2 diabetes (T2DM) on biochemical markers of bone metabolism. The study analyzed 14 observational studies and found that individuals with T2DM had reduced levels of markers associated with bone formation, such as Osteocalcin and P1NP, while levels of other bone formation markers, like Alkaline phosphatase and Bone-specific alkaline phosphatase, increased. The study also indicated a reduced rate of bone turnover in individuals with T2DM, which could increase the risk of osteoporosis despite higher bone mineral density. This research provides valuable insights into the relationship between T2DM and bone health. [Extracted from the article]

A recent study conducted at Naval Medical University in Shanghai, China, aimed to evaluate the effectiveness of a structured dietary intervention in reducing the risk of developing type 2 diabetes mellitus and improving associated metabolic health indicators. The study included 530 participants who were randomly assigned to either an intervention group with a Mediterranean-style diet or a control group with generic dietary guidelines. After 24 months, the incidence of type 2 diabetes mellitus was significantly lower in the intervention group, and participants in this group also experienced improvements in fasting glucose, lipid profiles, body composition, body weight, blood pressure, and body mass index. The study concluded that dietary intervention can substantially reduce the risk of developing type 2 diabetes mellitus and improve overall metabolic health. [Extracted from the article]

A study conducted by Fudan University in Shanghai, China, explored the association between B vitamin intake and the risk of type 2 diabetes (T2D), as well as the role of inflammation in mediating this relationship. The study analyzed data from 44,960 adults in the Shanghai Suburban Adult Cohort and Biobank and found negative correlations between B vitamins (except for B3) and T2D. Joint exposure to B1, B2, B6, B9, and B12 was also associated with a reduced T2D risk, with vitamin B6 accounting for a significant portion of the effects. Inflammation was identified as a partial mediator of this relationship. The study suggests that dietary intake of B vitamins may contribute to a reduced risk of T2D, mediated in part by inflammation. [Extracted from the article]

A recent report from investigators at Shanghai Jiao Tong University in China has identified a missense mutation in the isl1 gene that is associated with the development of type 2 diabetes. The researchers created a mouse model with the isl1(E283D) mutation and found that it led to impaired insulin secretion and elevated glucose levels, similar to the human diabetic phenotype. The study suggests that targeting the transcription factor ISL1 could be a potential avenue for the precise treatment of type 2 diabetes. This research was supported by the National Natural Science Foundation of China. [Extracted from the article]

A recent study conducted by researchers at Shanghai University of Traditional Chinese Medicine has identified phenylacetylglutamine (PAG) as a potential biomarker for type 2 diabetes mellitus (T2DM) with distal symmetric polyneuropathy (DSPN). The study analyzed plasma samples from healthy controls, T2DM patients, and DSPN patients using metabolomics. The results showed that PAG levels were significantly higher in the DSPN group compared to the control and T2DM groups, suggesting its potential as a biomarker for DSPN. Further research is needed to understand the role of PAG in the pathogenesis of DSPN. [Extracted from the article]

A study conducted by researchers at Shanghai Jiao Tong University explores the therapeutic potential of barley grain in the management of type 2 diabetes mellitus (T2DM). The study highlights the health benefits of barley on metabolic diseases and emphasizes the need for review articles specifically focused on the antidiabetic effects of barley. Barley grains have shown potential as a functional food for T2DM management due to their high dietary fiber content, diverse array of phytochemicals, and bioactive peptides. Further research is needed to establish the relationships between barley bioactive components and their specific antidiabetic capacity. [Extracted from the article]

A meta-analysis of randomized controlled trials conducted in Shanghai, China compared the efficacy and safety of insulin degludec/insulin aspart (IDegAsp) versus biphasic insulin aspart 30 (BIAsp 30) in patients with type 2 diabetes (T2D). The study found that IDegAsp was more effective than BIAsp 30 in improving fasting plasma glucose levels and reducing the daily average insulin dose. Additionally, IDegAsp significantly reduced the risk of nocturnal hypoglycemic events. However, there were no significant differences between the two groups in terms of body weight change, glycosylated hemoglobin, overall risk of hypoglycemic events, and adverse events. The researchers concluded that IDegAsp could effectively reduce FPG levels, insulin dosage, and the risk of nocturnal hypoglycemic events in T2D patients without increasing the overall risk of adverse events. [Extracted from the article]

A study conducted by researchers at Shanghai Jiao Tong University in China examined the relationship between daytime napping and glycemic control in people with type 2 diabetes. The study included 226 participants with type 2 diabetes, and glycemic control was measured using HbA1c levels. The researchers found that long napping duration (60 minutes or more) and morning napping were associated with poorer glycemic control, while restorative napping was associated with better glycemic control. The study suggests that daytime napping, specifically its duration and type, is an important factor that can be modified to improve glycemic control in individuals with type 2 diabetes. [Extracted from the article]

A study conducted by researchers at the University of Shanghai for Science and Technology explores the role of solute carriers (SLCs) in the treatment of type 2 diabetes mellitus (T2DM). SLCs are membrane transporter proteins that play a crucial role in energy metabolism by facilitating the transport of various substances, including glucose, fatty acids, amino acids, nucleotides, and ions. The activities of these transporters contribute to the development of T2DM, and SLC5A2 has emerged as a potential drug target for T2DM due to its role in renal glucose reabsorption. The study provides a comprehensive update on the biological activities and clinical relevance of SLC transporters in controlling glucose metabolism as potential drug targets for T2DM therapy. [Extracted from the article]

A study conducted by Fudan University in Shanghai, China, examined the association between depressive symptoms and the risk of cardiovascular diseases (CVD) in individuals with type 2 diabetes. The study included 17,031 participants from the UK Biobank who had type 2 diabetes and were free of depression. The researchers found that individuals with depressive symptoms had a higher risk of developing CVD, including coronary artery disease, ischemic stroke, peripheral arterial disease, and heart failure. The study suggests that screening for depressive symptoms in people with type 2 diabetes could help predict CVD outcomes. [Extracted from the article]

A study conducted by researchers at Fudan University in Shanghai, China, compared the efficacy and safety of two antidiabetic drugs, tirzepatide (Tir) and semaglutide (Sem), in treating type 2 diabetes mellitus (T2DM). The study analyzed data from 38 randomized clinical trials involving 34,166 participants. The results showed that Tir and Sem were both effective in reducing glycated hemoglobin (HbA1c) and body weight (BW) in T2DM patients who were obese or overweight. Tir demonstrated the most potent effect in reducing HbA1c and BW, followed by Sem. However, both drugs had a high incidence of gastrointestinal adverse events (GIAEs), although their safety profile was considered acceptable. [Extracted from the article]

A recent study conducted at Shanghai Changzheng Hospital in China investigated the effects of Dapagliflozin on renal fibrosis in rats with streptozotocin-induced type 2 diabetes mellitus (T2DM). The study found that Dapagliflozin effectively reduced blood glucose levels, renal tissue damage, and collagen deposition in the kidneys of diabetic rats. It also decreased the levels of blood urea nitrogen, serum creatinine, and urine protein, while increasing the expression of certain proteins associated with kidney health. The researchers concluded that Dapagliflozin may alleviate renal fibrosis in T2DM rats by inhibiting the TGF-beta 1/Smad pathway. [Extracted from the article]

A recent study conducted in Shanghai, China, compared the efficacy and safety of sodium-glucose cotransporter 2 inhibitors (SGLT-2i) for renal outcomes in patients with type 2 diabetes mellitus (T2DM). The study analyzed 30 trials involving 50,244 T2DM patients and found that canagliflozin had the greatest therapeutic effect in reducing the risk of renal impairment. Empagliflozin and canagliflozin were also found to be more effective than other SGLT-2i in preventing renal impairment. The study provides valuable insights into the use of SGLT-2i for T2DM patients with renal complications. [Extracted from the article]

A recent study conducted by researchers from Tongji University School of Medicine in Shanghai, China, explored the association between periodontitis, tooth loss, and the extent of coronary atherosclerosis in patients with type 2 diabetes mellitus. The study included 272 hospitalized patients who underwent a coronary artery calcium (CAC) CT scan. The results showed that clinical attachment loss (CAL) and the number of teeth lost were significantly higher in patients with moderate-to-severe coronary atherosclerosis. Salivary inflammatory factors and oral bacteremia were also found to be elevated in this group. The study suggests that tooth loss and CAL may be related to the extent of diabetic coronary atherosclerosis, and saliva inflammatory factors and oral bacteremia could serve as new biomarkers for this condition. [Extracted from the article]

Shanghai, People's Republic of China, Asia, Emerging Technologies, Health and Medicine, Machine Learning, Non-Insulin Dependent Diabetes Mellitus, Nutritional and Metabolic Diseases and Conditions, Peptide Hormones, Peptide Proteins, Proinsulin, Type 2 Diabetes, Reinforcement Learning Keywords: Shanghai; People's Republic of China; Asia; Emerging Technologies; Health and Medicine; Machine Learning; Non-Insulin Dependent Diabetes Mellitus; Nutritional and Metabolic Diseases and Conditions; Peptide Hormones; Peptide Proteins; Proinsulin; Reinforcement Learning; Type 2 Diabetes EN Shanghai People's Republic of China Asia Emerging Technologies Health and Medicine Machine Learning Non-Insulin Dependent Diabetes Mellitus Nutritional and Metabolic Diseases and Conditions Peptide Hormones Peptide Proteins Proinsulin Reinforcement Learning Type 2 Diabetes 1789 1789 1 11/06/23 20231106 NES 231106 2023 NOV 6 (NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- Data detailed on Nutritional and Metabolic Diseases and Conditions - Type 2 Diabetes have been presented. [Extracted from the article]

Shanghai, People's Republic of China, Asia, Biomarkers, Cardiovascular Diseases and Conditions, Diabetes Mellitus, Diagnostics and Screening, Endocrine System Diseases and Conditions, Endocrinology, Genetics, Glucose Metabolism Disorders, Health and Medicine, Hematology, Metabolic Diseases and Conditions, Non-Insulin Dependent Diabetes Mellitus, Nutritional and Metabolic Diseases and Conditions, Type 2 Diabetes, Vascular Diseases and Conditions Data on Vascular Diseases and Conditions Detailed by Researchers at Second Military Medical University (Serum Exosomal Hsa circrna 0001842 Is the Potential Biomarker for Diagnosing Lower Limb Vascular Disease In Type 2 Diabetes Mellitus) Keywords: Shanghai; People's Republic of China; Asia; Biomarkers; Cardiovascular Diseases and Conditions; Diabetes Mellitus; Diagnostics and Screening; Endocrine System Diseases and Conditions; Endocrinology; Genetics; Glucose Metabolism Disorders; Health and Medicine; Hematology; Metabolic Diseases and Conditions; Non-Insulin Dependent Diabetes Mellitus; Nutritional and Metabolic Diseases and Conditions; Type 2 Diabetes; Vascular Diseases and Conditions EN Shanghai People's Republic of China Asia Biomarkers Cardiovascular Diseases and Conditions Diabetes Mellitus Diagnostics and Screening Endocrine System Diseases and Conditions Endocrinology Genetics Glucose Metabolism Disorders Health and Medicine Hematology Metabolic Diseases and Conditions Non-Insulin Dependent Diabetes Mellitus Nutritional and Metabolic Diseases and Conditions Type 2 Diabetes Vascular Diseases and Conditions 232 232 1 10/30/23 20231030 NES 231030 2023 OCT 30 (NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- Data detailed on Cardiovascular Diseases and Conditions - Vascular Diseases and Conditions have been presented. [Extracted from the article]

For more information on this research see: Discrepancies In Vessel Density and Blood Flow Distribution In Different Areas of the Iris Among Pediatric Type 1 Diabetes Mellitus and Adult Type 2 Diabetes Mellitus Patients. Keywords: Shanghai; People's Republic of China; Asia; Diabetes Mellitus; Endocrine System Diseases and Conditions; Endocrinology; Glucose Metabolism Disorders; Health and Medicine; Hospitals; Insulin Dependent Diabetes Mellitus; Metabolic Diseases and Conditions; Non-Insulin Dependent Diabetes Mellitus; Nutritional and Metabolic Diseases and Conditions; Pediatrics; Type 1 Diabetes; Type 2 Diabetes EN Shanghai People's Republic of China Asia Diabetes Mellitus Endocrine System Diseases and Conditions Endocrinology Glucose Metabolism Disorders Health and Medicine Hospitals Insulin Dependent Diabetes Mellitus Metabolic Diseases and Conditions Non-Insulin Dependent Diabetes Mellitus Nutritional and Metabolic Diseases and Conditions Pediatrics Type 1 Diabetes Type 2 Diabetes 158 158 1 09/19/23 20230922 NES 230922 2023 SEP 18 (NewsRx) -- By a News Reporter-Staff News Editor at Pediatrics Week -- Fresh data on Nutritional and Metabolic Diseases and Conditions - Type 1 Diabetes are presented in a new report. This study aims to investigate differences in iris blood flow indices between pediatric type 1 diabetes mellitus (T1DM) patients and adult type 2 diabetes mellitus (T2DM) patients.". [Extracted from the article]

Keywords: Shanghai; People's Republic of China; Asia; Cancer; Carcinomas; Clinical Research; Clinical Trials and Studies; Digestive System Surgical Procedures; Health and Medicine; Hepatectomy; Hospitals; Liver Cancer; Non-Insulin Dependent Diabetes Mellitus; Nutritional and Metabolic Diseases and Conditions; Oncology; Surgery; Type 2 Diabetes EN Shanghai People's Republic of China Asia Cancer Carcinomas Clinical Research Clinical Trials and Studies Digestive System Surgical Procedures Health and Medicine Hepatectomy Hospitals Liver Cancer Non-Insulin Dependent Diabetes Mellitus Nutritional and Metabolic Diseases and Conditions Oncology Surgery Type 2 Diabetes 627 627 1 09/19/23 20230918 NES 230918 2023 SEP 19 (NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- Investigators publish new report on Nutritional and Metabolic Diseases and Conditions - Type 2 Diabetes. Compared to the patients without T2D, those with T2D had higher blood glucose measurements within 1 month (33 vs. 7) and 1 year (46.5 vs. 22.5, P<0.001) of surgery. [Extracted from the article]

According to the news reporters, the research concluded: "The diastolic BP within the optimal target range was considerably important for reducing the risk of myocardial infarction, even when systolic BP was under stable control." Keywords: Shanghai; People's Republic of China; Asia; Blood Pressure; Cardiology; Cardiovascular; Cardiovascular Research; Health and Medicine; Heart Attack; Heart Disease; Heart Disorders and Diseases; Hemodynamics; Myocardial Infarction; Myocardial Ischemia; Non-Insulin Dependent Diabetes Mellitus; Nutritional and Metabolic Diseases and Conditions; Risk and Prevention; Type 2 Diabetes; Vascular Diseases and Conditions EN Shanghai People's Republic of China Asia Blood Pressure Cardiology Cardiovascular Cardiovascular Research Health and Medicine Heart Attack Heart Disease Heart Disorders and Diseases Hemodynamics Myocardial Infarction Myocardial Ischemia Non-Insulin Dependent Diabetes Mellitus Nutritional and Metabolic Diseases and Conditions Risk and Prevention Type 2 Diabetes Vascular Diseases and Conditions 375 375 1 09/11/23 20230911 NES 230911 2023 SEP 11 (NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- Research findings on Nutritional and Metabolic Diseases and Conditions - Type 2 Diabetes are discussed in a new report. [Extracted from the article]

Shanghai, People's Republic of China, Asia, Health and Medicine, Non-Insulin Dependent Diabetes Mellitus, Nutritional and Metabolic Diseases and Conditions, Type 2 Diabetes Keywords: Shanghai; People's Republic of China; Asia; Health and Medicine; Non-Insulin Dependent Diabetes Mellitus; Nutritional and Metabolic Diseases and Conditions; Type 2 Diabetes EN Shanghai People's Republic of China Asia Health and Medicine Non-Insulin Dependent Diabetes Mellitus Nutritional and Metabolic Diseases and Conditions Type 2 Diabetes 103 103 1 08/21/23 20230821 NES 230821 2023 AUG 21 (NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- New research on Nutritional and Metabolic Diseases and Conditions - Type 2 Diabetes is the subject of a report. [Extracted from the article]

Keywords: Shanghai; People's Republic of China; Asia; Health and Medicine; Non-Insulin Dependent Diabetes Mellitus; Nutritional and Metabolic Diseases and Conditions; Type 2 Diabetes EN Shanghai People's Republic of China Asia Health and Medicine Non-Insulin Dependent Diabetes Mellitus Nutritional and Metabolic Diseases and Conditions Type 2 Diabetes 297 297 1 05/29/23 20230529 NES 230529 2023 MAY 29 (NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- New research on Nutritional and Metabolic Diseases and Conditions - Type 2 Diabetes is the subject of a report. Shanghai, People's Republic of China, Asia, Health and Medicine, Non-Insulin Dependent Diabetes Mellitus, Nutritional and Metabolic Diseases and Conditions, Type 2 Diabetes. [Extracted from the article]

Keywords: Shanghai; People's Republic of China; Asia; Diabetic Angiopathies; Diabetic Retinopathy; Eye Diseases and Conditions; Health and Medicine; Non-Insulin Dependent Diabetes Mellitus; Nutritional and Metabolic Diseases and Conditions; Ophthalmology; Retinal Diseases and Conditions; Retinopathy; Risk and Prevention; Type 2 Diabetes; Vascular Diseases and Conditions EN Shanghai People's Republic of China Asia Diabetic Angiopathies Diabetic Retinopathy Eye Diseases and Conditions Health and Medicine Non-Insulin Dependent Diabetes Mellitus Nutritional and Metabolic Diseases and Conditions Ophthalmology Retinal Diseases and Conditions Retinopathy Risk and Prevention Type 2 Diabetes Vascular Diseases and Conditions 229 229 1 05/08/23 20230508 NES 230508 2023 MAY 8 (NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- A new study on Nutritional and Metabolic Diseases and Conditions - Type 2 Diabetes is now available. Shanghai, People's Republic of China, Asia, Diabetic Angiopathies, Diabetic Retinopathy, Eye Diseases and Conditions, Health and Medicine, Non-Insulin Dependent Diabetes Mellitus, Nutritional and Metabolic Diseases and Conditions, Ophthalmology, Retinal Diseases and Conditions, Retinopathy, Risk and Prevention, Type 2 Diabetes, Vascular Diseases and Conditions. [Extracted from the article]

Keywords: Shanghai; People's Republic of China; Asia; Health and Medicine; Non-Insulin Dependent Diabetes Mellitus; Nutritional and Metabolic Diseases and Conditions; Type 2 Diabetes EN Shanghai People's Republic of China Asia Health and Medicine Non-Insulin Dependent Diabetes Mellitus Nutritional and Metabolic Diseases and Conditions Type 2 Diabetes 110 110 1 04/24/23 20230424 NES 230424 2023 APR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- Researchers detail new data in Nutritional and Metabolic Diseases and Conditions - Type 2 Diabetes. Shanghai, People's Republic of China, Asia, Health and Medicine, Non-Insulin Dependent Diabetes Mellitus, Nutritional and Metabolic Diseases and Conditions, Type 2 Diabetes. [Extracted from the article]

Keywords: Shanghai; People's Republic of China; Asia; Diabetic Neuropathy; Health and Medicine; Nervous System Diseases and Conditions; Neuromuscular Diseases and Conditions; Non-Insulin Dependent Diabetes Mellitus; Nutritional and Metabolic Diseases and Conditions; Peripheral Nervous System Diseases and Conditions; Polyneuropathies; Risk and Prevention; Type 2 Diabetes EN Shanghai People's Republic of China Asia Diabetic Neuropathy Health and Medicine Nervous System Diseases and Conditions Neuromuscular Diseases and Conditions Non-Insulin Dependent Diabetes Mellitus Nutritional and Metabolic Diseases and Conditions Peripheral Nervous System Diseases and Conditions Polyneuropathies Risk and Prevention Type 2 Diabetes 189 189 1 04/24/23 20230424 NES 230424 2023 APR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- Fresh data on Nutritional and Metabolic Diseases and Conditions - Type 2 Diabetes are presented in a new report. Shanghai, People's Republic of China, Asia, Diabetic Neuropathy, Health and Medicine, Nervous System Diseases and Conditions, Neuromuscular Diseases and Conditions, Non-Insulin Dependent Diabetes Mellitus, Nutritional and Metabolic Diseases and Conditions, Peripheral Nervous System Diseases and Conditions, Polyneuropathies, Risk and Prevention, Type 2 Diabetes. [Extracted from the article]

The news reporters obtained a quote from the research from Shanghai JiaoTong University, "We sought to characterize genome-wide alterations inplacental gene methylations in fetal overgrowth and the associationswith metabolic health biomarkers including leptin, adiponectin and fetalgrowth factors. Adiponectin in cord blood wascorrelated with its gene methylation in the placenta, while leptin andfetal growth factors (insulin, IGF-1, IGF-2) were not. Nutritional and Metabolic Diseases and Conditions - Type 2 Diabetes Research findings on Nutritional and Metabolic Diseases andConditions - Type 2 Diabetes are discussed in a new report. [Extracted from the article]